Month: September 2025

Highlighting Continued Progress with EMA Regarding a Potential Conditional Marketing Authorization Submission for Iopofosine I 131 to Treat Waldenstrom Macroglobulinemia (WM) in the EU; Decision on Track for Late 3Q25/Early 4Q25 Intention to Pursue an Accelerated Approval with the U.S. Food and Drug Administration for Iopofosine I 131 as a Treatment for WM Advancing Auger-Emitting Radiopharmaceutical Product Candidate into Phase 1b Clinical Trial for the Treatment of Triple-Negative Breast Cancer in 4Q25 FLORHAM PARK, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Company management will participate at the upcoming Oppenheimer 3rd Annual Targeted...

Customer Boom and M&A on Deck DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that TEN Holdings (NASDAQ: XHLD), a provider of event planning, production, and broadcasting services through its operating subsidiary Ten Events, is demonstrating robust execution and accelerating growth, according to a recent update from All-Star Analyst Barry M. Sine, CFA, CMT. Sine, a two-time Wall Street Journal and Financial Times All-Star Analyst, reiterated his full-year revenue estimate, highlighting TEN Holdings’ strong customer traction, ahead-of-schedule progress on its Ten Events Pro (“Ten Pro”) SaaS platform, and promising merger and acquisition (M&A) opportunities. The report highlights accelerating...

DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, analyses Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, appointment of Kenneth Le as Managing Director of Prodigy Silk Ltd, the Company’s wholly owned recombinant spider silk production subsidiary in Southeast Asia. The strategic promotion of Le comes at a pivotal moment. With the Company now preparing to kick off its revamped spider silk production model and focus on its first sample deliveries to three high-profile global clients, Le’s leadership is expected to catalyze the transition from production scale-up to commercial super fiber deployment. Operational Excellence for a Next-Gen...

SINGAPORE, Sept. 09, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it has secured exclusive licensing rights to Southeast Asia’s first medical waste recycling technology developed under the oversight of the United Nations Industrial Development Organization (UNIDO) and the Global Environment Facility (GEF), the major alliance supporting developing countries in achieving global environmental benefits.  The license, signed by Cuprina with China-based Zhejiang Heliang Technology Co., Ltd., covers Singapore and an option to expand into ten additional...

VANCOUVER, British Columbia, Sept. 09, 2025 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Company”) (TSX Venture Exchange: FNC) is pleased to announce prospecting and soil geochemical exploration results of an exploration program conducted by Acadian Gold, a joint venture with Lode Gold Resources Inc. for the advancement of a district scale, 445 km² land package located in a highly prospective region for gold and polymetallic mineral discovery, in northern New Brunswick. Acadian Gold is one of the largest under-explored holdings in this emerging gold camp, with two key properties; McIntyre Brook, adjacent to Puma Exploration’s Williams Brook Project (which holds an option agreement with Kinross Gold), and Riley Brook, a significantly sized property surrounded by recent claims acquisitions made by Kenorland Minerals....

CALGARY, Alberta, Sept. 09, 2025 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica” or “Recon”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) is pleased to announce that on September 8, 2025, it has entered into a production sharing contract (the “PSC”) and a joint venture agreement, led by Recon along with Record Resources Inc. (“Record”) (TSXV: REC), the Republic of Gabon and its national oil and gas company, Gabon Oil Company (“GOC”). The PSC is for the exploration, appraisal, development and production of oil and gas on Gabon offshore Block C-7, renamed Ngulu (“Ngulu”). Under the terms of the joint venture, Recon will be the designated operator, with a 55% working interest, Record with a 20% working interest, the Gabon Oil Company with a 15% working interest and the Republic of Gabon...

OAK BROOK, Ill., Sept. 09, 2025 (GLOBE NEWSWIRE) — Portillo’s, Inc. (NASDAQ: PTLO) announces the following event:What:   Portillo’s Management Fireside Chat and Q&A    Michael Osanloo, President and CEO    Michelle Hook, CFO    Brian Mullan, Piper Sandler Restaurant Analyst     When:   Wednesday, September 10 at 4:30 p.m. EDT     Where:   investors.portillos.com     How:   Live webcast (web address above)     Contact:   Chris Brandon, Vice President of Investor Relations    312.931.5578    cbrandon@portillos.com      *This webcast event will be archived on the Portillo’s Investor Relations website for replay. About Portillo’sPortillo’s (NASDAQ: PTLO) is a one-of-a-kind brand that has grown from a small hot dog trailer in Chicago to more than 90 restaurants across 10 states. Known...

Appili Non-Clinical Director to join NATO and allied representatives and present ATI-1701 biodefense vaccine as a potential solution to the tularemia threat HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Carl Gelhaus, Ph.D., Director of Non-Clinical Research, will participate in the NATO Chemical, Biological, Radiological and Nuclear (“CBRN”) Conference, taking place September 8–10, 2025, in Switzerland. Dr. Gelhaus will join NATO and allied representatives and present an update on Appili’s biodefense vaccine program, highlighting ATI-1701, the company’s potential first-in-class vaccine candidate designed to prevent infection...